Announcement: Check out our lab's profile on the Department of Neurology's website.
Our main research focus is the abnormal self-association of proteins into toxic oligomers, aggregates, and amyloid fibrils and the involvement of these aberrant protein assemblies in human diseases. We study the molecular interactions involved in these processes and explore novel tools to inhibit the formation of the toxic assemblies.
Abnormal protein oligomerization and aggregation cause, or are involved in, over 50 diseases called amyloidoses or proteinopathies. Of this large family of diseases, we study mainly Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). Another focus of our lab is the analysis of biomarkers that can improve the diagnosis and facilitate drug development for these diseases.
One of our major projects is the development of "Molecular Tweezers" as novel drug candidates for proteinopathies. We are leading a project called Breakthrough Treatment for Degenerative Diseases (www.BTDD.org) that involves collaboration with multiple laboratories at UCLA and around the world.